The EU’s chief negotiator for Covid-19 vaccines, Sandra Gallina, has made no secret of her annoyance at AstraZeneca’s behaviour. Speaking to MEPs in the Committee on Budgets, on 23 March, she also hinted that the still-secret contracts would soon be published and that a seventh and final contract, this time with Novavax, could be added to the EU’s current portfolio.
The EU will use all possible tools vis-à-vis AstraZeneca
“AstraZeneca’s poor performance has damaged the reputation...